Affirmative action

Minister O'Regan receives Task Force report on Employment Equity Act modernization

Retrieved on: 
Monday, December 11, 2023
Senior, Research, Employment, Organization, Picot task force, Indigenous peoples, First Nations, LL.M, Workforce, Act, Queen's University, Disability, Government, Rights, Canada Act 1982, McGill University, Religion, Human Rights Day, Faculty, Accessible Canada Act, Task force, Federal, Affirmative action, The Act, Person, University, History, United Nations General Assembly, International law, Speech, Heel, Human rights, Columbia University, Workplace, Universal, Legislation, United Nations, Nursing, Management, Law

The Government launched a task force chaired by Professor Adelle Blackett to undertake the most comprehensive review of the Employment Equity Act since its introduction in 1986.

Key Points: 
  • The Government launched a task force chaired by Professor Adelle Blackett to undertake the most comprehensive review of the Employment Equity Act since its introduction in 1986.
  • Today, Minister of Labour, Seamus O'Regan Jr. and Professor Blackett announced the release of the Employment Equity Act Review Task Force's final report: A Transformative Framework to Achieve and Sustain Employment Equity .
  • On behalf of the Government, Minister O'Regan thanks Professor Blackett and the Task Force for carrying out this important work.
  • On July 14, 2021, the Government launched the Employment Equity Act Review Task Force , which had the mandate to undertake an independent review of the Act.

CIBC receives inaugural Indigenous Reconciliation award from Canadian federal Labour Program

Retrieved on: 
Thursday, November 23, 2023
Indigenous peoples, CCAB, CIBC, Workforce, History, Student, Culture, Employment, Affirmative action, Labour, Innovation, Mining, Indigenous

TORONTO, Nov. 23, 2023 /CNW/ - CIBC today announced it has received the inaugural Indigenous Reconciliation award as part of the 2023 Employment Equity Achievement Awards (EEAA) organized by the Canadian federal Labour program.

Key Points: 
  • TORONTO, Nov. 23, 2023 /CNW/ - CIBC today announced it has received the inaugural Indigenous Reconciliation award as part of the 2023 Employment Equity Achievement Awards (EEAA) organized by the Canadian federal Labour program.
  • This new category within the EEAA program recognizes employers who have demonstrated outstanding commitment to reconciliation with Indigenous peoples including outreach and partnerships with local Indigenous communities, innovative approaches to Indigenous recruitment, employee training programs on Indigenous reconciliation, as well as supporting engagement with Indigenous communities and stakeholders on employment equity.
  • Conducting employee training programs for Canadian team members to help expand understanding of the unique history of the Indigenous Peoples in Canada.
  • Partnering with the Canadian Council for Aboriginal Business (CCAB) and Canadian Aboriginal Minority Supplier Council (CAMSC) to connect with Indigenous suppliers.

Jazz honoured with Indigenous Reconciliation award from Government of Canada

Retrieved on: 
Thursday, November 23, 2023
Aviation, Indigenous peoples, North American Indigenous Games, Policy, Learning, Government, Flight attendant, CHR, Jazz Aviation, Indigenous self-government in Canada, Affirmative action, Knowledge, TSX, Education, Management, Indigenous, Jazz, Chorus

HALIFAX, NS, Nov. 23, 2023 /CNW/ - Chorus Aviation Inc. ('Chorus') (TSX: CHR) is pleased to announce that its subsidiary Jazz Aviation LP ('Jazz') has received an inaugural year Indigenous Reconciliation award from the Government of Canada's Employment Equity Achievement Awards on November 22, 2023.

Key Points: 
  • HALIFAX, NS, Nov. 23, 2023 /CNW/ - Chorus Aviation Inc. ('Chorus') (TSX: CHR) is pleased to announce that its subsidiary Jazz Aviation LP ('Jazz') has received an inaugural year Indigenous Reconciliation award from the Government of Canada's Employment Equity Achievement Awards on November 22, 2023.
  • The Indigenous Reconciliation award recognizes employers who have demonstrated outstanding commitment to reconciliation with Indigenous peoples.
  • "Jazz is proud to have an employee base that reflects the diversity of the communities we serve," said Randolph deGooyer, President, Jazz.
  • "This is outstanding recognition for Jazz and an honour to be included in the inaugural class of award recipients for Indigenous reconciliation," said Colin Copp, President and Chief Executive Officer, Chorus.

Minister O'Regan recognizes employers' outstanding achievements in making their workplaces diverse and inclusive

Retrieved on: 
Wednesday, November 22, 2023
Senior, Employment, Organization, Indigenous peoples, Annual report, Government, Affirmative action, Employment equity (Canada), Workplace, Creative industries

Today, Minister of Labour, Seamus O'Regan Jr., announced the 2023 Employment Equity Achievement Awards winners during a ceremony held in Ottawa, Ontario.

Key Points: 
  • Today, Minister of Labour, Seamus O'Regan Jr., announced the 2023 Employment Equity Achievement Awards winners during a ceremony held in Ottawa, Ontario.
  • Through these awards, the Government of Canada recognizes federally regulated private-sector employers and federal contractors for their outstanding commitment to and achievements in implementing employment equity in their organization.
  • The event also provided a forum for employers to share best practices and challenges and learn more about winners' achievements.
  • Minister O'Regan presented 34 awards to 19 employers in the following categories: sector distinction; outstanding commitment to employment equity; innovation; employment equity champion; and Indigenous reconciliation.

Affirmity Announces New Additions to Affirmative Action and EEO Compliance Training Catalog

Retrieved on: 
Wednesday, November 8, 2023
EEO, DE, Workforce, Ethics, Catalog, Affirmative action, Science and technology in Asia, Nursing, DALLAS

DALLAS, Nov. 8, 2023 /PRNewswire-PRWeb/ -- Affirmity, a market leader in the provision of workforce compliance and DE&I (diversity, equity, and inclusion) solutions, has announced a major new refresh of its Affirmative Action and EEO compliance training catalog.

Key Points: 
  • DALLAS, Nov. 8, 2023 /PRNewswire-PRWeb/ -- Affirmity, a market leader in the provision of workforce compliance and DE&I (diversity, equity, and inclusion) solutions , has announced a major new refresh of its Affirmative Action and EEO compliance training catalog .
  • The available training covers all federally-mandated affirmative action, ethics, and workplace compliance topics and, where appropriate, has been tailored to the specific needs of different audiences.
  • The available training covers all federally-mandated affirmative action, ethics, and workplace compliance topics and, where appropriate, has been tailored to the specific needs of different audiences.
  • The range of eLearning courses available includes:
    For a description of these modules and further information about Affirmity's Affirmative Action and EEO compliance training offering, please visit the Affirmity website .

Thurgood Marshall’s Legacy Is Alive And Thriving Thanks to Focus on Equity & Inclusion

Retrieved on: 
Friday, October 27, 2023
Supreme court, HBCU, Chicago, Mentorship, Education, Fortune 500, History, Student, Workforce, Historically black colleges and universities, Growth, Chicago State University, Partnership, Affirmative action, Social justice, Lincoln University, Thurgood Marshall College Fund, Constitution, Thurgood Marshall, DNA, Nursing, Management, Creative industries

Like many in attendance, Williams was startled to discover that the percentage of Black students attending colleges in Illinois decreased by 37 percent.

Key Points: 
  • Like many in attendance, Williams was startled to discover that the percentage of Black students attending colleges in Illinois decreased by 37 percent.
  • The fight for equity is the engine that fuels the mission of Thurgood Marshall College Fund.
  • It is also a passion to continue the work and enhance the legacy of Justice Thurgood Marshall, a two-time HBCU graduate of Lincoln University and Howard.
  • He was dignified and believed with the Constitution on his side; he could venture forward with essential change.

University of Phoenix Leadership Join UPCEA Webinar on Diversity Fatigue and DE&I in Post SCOTUS Ruling Webinar

Retrieved on: 
Wednesday, October 25, 2023
Professional Services, Courts, Education, DEI (Diversity, Equity and Inclusion), Public Policy, Government, Continuing, University, Online, Woman, Research, Georgetown University, Higher Learning Commission, University of Illinois at Chicago, Underwood, CHEA, Council for Higher Education Accreditation, Grinnell College, Supreme court, SCOTUS, SCCE, OLC, DEIB, Teaching, Social justice, Online and offline, Certification, Fatigue, Professional practice of behavior analysis, Publication, DEI, University of Phoenix, Growth, Affirmative action, Cornell University, Society, UPCEA, Strategic planning, PCO, DE, Climate, Online Learning Consortium, Environment, Kansas Supreme Court, Swiss Insurance Association, Nursing, Equity, Inclusion, Diversity, Council, Ethics

The webinar explored the concept of "Diversity Fatigue," which encompasses the emotional strain experienced by postsecondary leaders when their institution's DE&I commitment differs from their personal dedication to the cause.

Key Points: 
  • The webinar explored the concept of "Diversity Fatigue," which encompasses the emotional strain experienced by postsecondary leaders when their institution's DE&I commitment differs from their personal dedication to the cause.
  • "University of Phoenix serves a diverse student population, and our commitment to serving that population is part of the equation.
  • Earlier this year, she was selected to serve on the UPCEA Board of Directors’ Diversity & Inclusive Excellence Committee for a one-year term.
  • Dr. Underwood earned her Ph.D. in Educational Policy from the University of Illinois at Chicago, Executive Certificate in Strategic Diversity and Inclusion Management from Georgetown University, and Diversity and Inclusion for Human Resources Certification from Cornell University.

BeiGene Presentations at ESMO 2023 Demonstrate Robust Clinical Strategy for Tislelizumab as Monotherapy and in Combination with Pipeline Assets

Retrieved on: 
Monday, October 16, 2023
Oncology, Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, SSE, Congress, European, Food, Abstract, TIS, PD-L1, Trial of the century, Programmed cell death protein 1, BGNE, Medicine, OCI, FDA, ESMO, Biologics license application, MSI-H, Neoplasm, Regulation of tobacco by the U.S. Food and Drug Administration, European Society for Medical Oncology, Affirmative action, ESCC, Pharmaceutical industry, Tislelizumab, BeiGene, Patient, EU

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced the presentation of promising new data showcasing BeiGene’s robust, science-driven solid tumor portfolio of commercialized and pipeline medicines at the European Society for Medical Oncology (ESMO) Congress 2023.

Key Points: 
  • BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced the presentation of promising new data showcasing BeiGene’s robust, science-driven solid tumor portfolio of commercialized and pipeline medicines at the European Society for Medical Oncology (ESMO) Congress 2023.
  • “Tislelizumab is the cornerstone of BeiGene’s diverse pipeline of pan-solid tumor programs for the next wave of immuno-oncology targets.
  • Additionally, the U.S. Food and Drug Administration (FDA) recently accepted for review a Biologics License Application for tislelizumab as a first-line treatment for patients with unresectable, recurrent, locally advanced, or metastatic ESCC.
  • Long-term Follow-up of a Phase 2 Study of Tislelizumab (TIS) Monotherapy in Patients (pts) With Previously Treated, Locally Advanced, Unresectable or Metastatic Microsatellite Instability-high (MSI-H) or Mismatch Repair-deficient (dMMR) Solid Tumors.

New Study Demonstrates Lunit SCOPE IO's Effectiveness to Predict Biliary Tract Cancer Therapy Outcomes - Findings to be Presented at the ESMO 2023

Retrieved on: 
Monday, October 16, 2023
Congress, H&E, Mayo Clinic, Tumor microenvironment, Abstract, Research, NSCLC, AI, HNSCC, Therapy, Data, Lung cancer, Cancer, TIL, Marie Cassidy, European Society for Medical Oncology, ESMO, Oncology, Cholangiocarcinoma, PPV, Genotype, Head, Neoplasm, ICI, Phenotype, Affirmative action, Progression-free survival, HER2, MET, Patient, WSI, BTC, Medical device, Medical imaging

SEOUL, South Korea, Oct. 16, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the presentation of 9 studies at the upcoming European Society for Medical Oncology (ESMO) 2023 Congress, to be held in Madrid, Spain, from October 20-24.

Key Points: 
  • A collaborative study indicated that AI-based immune phenotyping can predict therapy outcomes in advanced biliary tract cancer (BTC) patients who are planning to be treated with anti-PD-1 therapy.
  • In the study, the research team defined the immune phenotype of the WSI samples via Lunit SCOPE IO, Lunit's AI TIL (tumor-infiltrating lymphocytes) analyzer.
  • In another study, HER2 (human epidermal growth factor receptor-2) scoring in biliary tract cancer was evaluated using Lunit SCOPE HER2.
  • Another study aimed to predict multiple druggable mutations in non-small cell lung cancer (NSCLC) based on AI analysis of H&E images.

Lunit to Showcase 9 AI-based Research Results at ESMO 2023

Retrieved on: 
Tuesday, October 10, 2023
Congress, H&E, Fluorescence, Lung cancer, Abstract, Breast cancer, Breast, AI, Therapy, Safety, TIL, Patient, Spatial analysis, European Society for Medical Oncology, ESMO, Oncology, Collection, Leiomyosarcoma, Fluorescence in situ hybridization, Cholangiocarcinoma, Pathology, ICI, Colon cancer staging, Affirmative action, Prognosis, HER2, Research, DNA mismatch repair, Medical device, Medical imaging, Vaccine

SEOUL, South Korea, Oct. 10, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the presentation of 9 studies featuring its AI pathology research at the upcoming European Society for Medical Oncology (ESMO) 2023 Congress, scheduled to be held in Madrid, Spain, from October 20 to October 24, 2023.

Key Points: 
  • The highlighted abstracts for ESMO 2023 include:
    Lunit investigates AI's potential to predict multiple druggable mutations in non-small cell lung cancer from H&E stained images, paving the way for more efficient clinical workflows and treatment decisions.
  • In another study utilizing Lunit SCOPE HER2, Lunit assesses HER2 expression and TIL (Tumor-infiltrating lymphocyte) density in biliary tract cancer, providing valuable insights into the tumor microenvironment's role in treatment strategies.
  • "These groundbreaking abstracts showcase the power of the Lunit SCOPE suite in unraveling complex insights across various cancer types, from distinguishing tumor subtypes to predicting treatment responses," said Brandon Suh, CEO of Lunit.
  • For inquiries or to schedule a meeting with the Lunit team, please contact [email protected] .